Meridian Bioscience, Inc., Cincinnati, Ohio (VIVO) announced today that it has completed the acquisition of Magellan Biosciences, Inc. and its wholly owned subsidiary Magellan Diagnostics, Inc. Headquartered in Billerica, Massachusetts (near Boston), Magellan pioneered the engineering, development and manufacturing of FDA-cleared products for the testing of blood to diagnose lead poisoning in children and adults. Today, Magellan is the leading provider of point-of-care lead testing systems with placements in more than 6,500 physician offices and clinics nationwide. Its position in pediatric …
News & Updates
Convergence Healthcare Advises Lumora in its sale to ERBA Diagnostics Mannheim
MANNHEIM, Germany--(BUSINESS WIRE)--ERBA Diagnostics Mannheim GmbH, a global in vitro diagnostics company, today announced it has completed the acquisition of Lumora, a provider of state-of-the-art molecular diagnostic products for the clinical and industrial markets. Financial terms were not disclosed. The acquisition will see ERBA Diagnostics Mannheim add molecular diagnostics testing to its comprehensive suite of clinical testing products. ERBA Mannheim’s global network of direct sales and distribution, through its group companies in America, Europe, Russia, India and its knowledge of …
[Read more...] about Convergence Healthcare Advises Lumora in its sale to ERBA Diagnostics Mannheim
Convergence Healthcare Advises Lumora in the sale of its Heat Elution technology and IP to Roche
PLEASANTON, Calif., Aug. 24, 2015 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) has signed a definitive asset purchase agreement with Lumora for products associated with the unique, patent-protected Heat Elution1 technology for nucleic acid purification of multiple sample types including challenging formalin-fixed paraffin-embedded (FFPE) tumor samples. Roche plans to explore integrating this technology into its sequencing workflow solution. Today, nucleic acid purification technology from specimens including formalin-fixed tissues can be cumbersome and inefficient. Lumora's highly …
Seven Hills Advises CECity in $400 million sale to Premier
Premier, Inc. (NASDAQ:PINC), a leading healthcare improvement company, reached an agreement to acquire CECity, Inc., for $400 million. CECity is a privately-held, SaaS-based healthcare solutions provider, specializing in performance management and improvement, pay-for-value reporting and professional education. Both organizations are industry-leading influencers that complement one another as they help providers holistically deliver higher-quality, more cost-effective care. Premier unites an alliance of 3,400 hospitals and health systems, as well as 110,000 non-acute sites of care. CECity …
[Read more...] about Seven Hills Advises CECity in $400 million sale to Premier